{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The increased pathogenicity related to the familial A30P mutation is unlikely to be caused by a mutation-induced change in the conformation of aS aggregates.",
          "judgment": "Yes",
          "reasoning": "The paper clearly discusses the disease mechanism related to aS aggregation and its role in amyloidogenic diseases."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Structural properties under identical conditions (pH, buffer, cofactors), which is impossible for material extracted from the brain.",
          "judgment": "Yes",
          "reasoning": "The assays used (e.g., structural assays) are applicable to studying the disease mechanism of aS aggregation.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The variations in the solvent protection for different regions with b-structure are highly similar in A30P and wt aS.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly mention the use of both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls or provide details on experimental replicates.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "The study uses structural assays (e.g., solvent protection) which are standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "The assay type is broadly accepted historically as a standard technique in the field.",
          "next_step_or_outcome": "The functional evidence strength is Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "The functional evidence suggests that the A30P mutation does not cause significant changes in the conformation of aS aggregates compared to wild-type, supporting a benign role for this variant."
    }
  ]
}